Neurolens’ $67 Million Financing

Troutman Pepper advised MVM Partners on the deal. Neurolens, a company commercializing innovative solutions to optimize vision, completed a $67 million financing led by MVM Partners,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Apnimed’s Series C Financing

Troutman Pepper advised Apnimed on the deal. Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here